{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T11:47:55Z","timestamp":1769514475429,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.clinthera.2024.08.017","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T11:41:39Z","timestamp":1725968499000},"page":"883-890","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Risk Factors for E2SKAPE Infections and Mortality Among Liver Transplant Recipients"],"prefix":"10.1016","volume":"46","author":[{"given":"Xiaoxia","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenpeng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiting","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manjie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiquan","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.clinthera.2024.08.017_bib0001","doi-asserted-by":"crossref","first-page":"E176","DOI":"10.25011\/cim.v40i5.28623","article-title":"Association between donor and recipient Interleukin-18 gene polymorphisms and the risk of infection after liver transplantation","volume":"40","author":"Shi","year":"2017","journal-title":"Clin Invest Med"},{"issue":"6","key":"10.1016\/j.clinthera.2024.08.017_bib0002","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/1348-0421.12785","article-title":"Bacterial infections in the early period after liver transplantation in adults: a prospective single-center cohort study","volume":"64","author":"Jafarpour","year":"2020","journal-title":"Microbiol Immunol"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2024.08.017_bib0003","first-page":"145","article-title":"Early postoperative infections after liver transplant","volume":"16","author":"Ayvazoglu Soy","year":"2018","journal-title":"Exp Clin Transplant"},{"issue":"3","key":"10.1016\/j.clinthera.2024.08.017_bib0004","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/MOT.0000000000000083","article-title":"Bacterial biliary tract infections in liver transplant recipients","volume":"19","author":"van Delden","year":"2014","journal-title":"Curr Opin Organ Transplant"},{"issue":"3","key":"10.1016\/j.clinthera.2024.08.017_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.00181-19","article-title":"Antimicrobial resistance in ESKAPE pathogens","volume":"33","author":"De Oliveira","year":"2020","journal-title":"Clin Microbiol Rev"},{"issue":"12","key":"10.1016\/j.clinthera.2024.08.017_bib0006","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s10096-019-03673-1","article-title":"Resistance reported from China antimicrobial surveillance network (CHINET) in 2018","volume":"38","author":"Hu","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"10.1016\/j.clinthera.2024.08.017_bib0007","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/tid.12278","article-title":"Frequency and clinical outcomes of ESKAPE bacteremia in solid organ transplantation and the risk factors for mortality","volume":"16","author":"Ye","year":"2014","journal-title":"Transpl Infect Dis"},{"issue":"138","key":"10.1016\/j.clinthera.2024.08.017_bib0008","first-page":"346","article-title":"The risk factors for mortality and septic shock in liver transplant recipients with ESKAPE bacteremia","volume":"62","author":"Ouyang","year":"2015","journal-title":"Hepatogastroenterology"},{"issue":"9","key":"10.1016\/j.clinthera.2024.08.017_bib0009","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1097\/TP.0b013e3182a049fd","article-title":"Risk factors and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in solid-organ transplant recipients","volume":"96","author":"Bodro","year":"2013","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.clinthera.2024.08.017_bib0010","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1016\/j.transproceed.2014.08.049","article-title":"Risk factors for mortality in liver transplant recipients with ESKAPE infection","volume":"46","author":"Song","year":"2014","journal-title":"Transplant Proc"},{"issue":"1","key":"10.1016\/j.clinthera.2024.08.017_bib0011","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ajic.2019.06.008","article-title":"Microbiology and prevalence of E2SKAPE-resistant strains in catheter-related bloodstream infections in patients with cancer","volume":"48","author":"de la Cruz-Hern\u00e1ndez","year":"2020","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.clinthera.2024.08.017_bib0012","unstructured":"European Centre for Disease Prevention and Control (ECDC). Healthcare-associated infections acquired in intensive care units. Annual epidemiological report for 2017. Available at: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/AER_for_2017-HAI.pdf."},{"issue":"3","key":"10.1016\/j.clinthera.2024.08.017_bib0013","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"10.1016\/j.clinthera.2024.08.017_bib0014","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1399-3062.2009.00421.x","article-title":"Multidrug resistant gram-negative bacilli as predominant bacteremic pathogens in liver transplant recipients","volume":"11","author":"Shi","year":"2009","journal-title":"Transpl Infect Dis"},{"issue":"5","key":"10.1016\/j.clinthera.2024.08.017_bib0015","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","article-title":"CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting","volume":"36","author":"Horan","year":"2008","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.clinthera.2024.08.017_bib0016","series-title":"Clinical Microbiology Procedures Handbook","first-page":"36","article-title":"Microbiological techniques & methods- laboratory manuals","author":"Isenberg","year":"2007"},{"key":"10.1016\/j.clinthera.2024.08.017_bib0017","series-title":"Performance Standards for Antimicrobial Susceptibility Testing","first-page":"100","year":"2016"},{"key":"10.1016\/j.clinthera.2024.08.017_bib0018","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.2147\/IDR.S226217","article-title":"Prevalence, risk factors and treatment of the most common gram-negative bacterial infections in liver transplant recipients: a review","volume":"12","author":"Shafiekhani","year":"2019","journal-title":"Infect Drug Resist"},{"issue":"2(Special)","key":"10.1016\/j.clinthera.2024.08.017_bib0019","first-page":"699","article-title":"Antimicrobial activity of AgNO3 nanoparticles synthesized using Valeriana wallichii against ESKAPE pathogens","volume":"36","author":"Shah","year":"2023","journal-title":"Pak J Pharm Sci"},{"key":"10.1016\/j.clinthera.2024.08.017_bib0020","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.2147\/IDR.S306688","article-title":"Characterisation of ESKAPE pathogens with special reference to multidrug resistance and biofilm production in a Nepalese hospital","volume":"14","author":"Pandey","year":"2021","journal-title":"Infect Drug Resist"},{"issue":"9","key":"10.1016\/j.clinthera.2024.08.017_bib0021","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.3390\/diagnostics12092248","article-title":"The Association of Organ Preservation Fluid Pathogens with early infection-related events after kidney transplantation","volume":"12","author":"Li","year":"2022","journal-title":"Diagnostics (Basel)."},{"key":"10.1016\/j.clinthera.2024.08.017_bib0022","doi-asserted-by":"crossref","first-page":"977","DOI":"10.2147\/IDR.S446582","article-title":"Development of a risk prediction model for infection after kidney transplantation transmitted from bacterial contaminated preservation solution","volume":"17","author":"Guo","year":"2024","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.clinthera.2024.08.017_bib0023","doi-asserted-by":"crossref","DOI":"10.1007\/s40620-024-01972-1","article-title":"Assessing the impact of positive cultures in preservation fluid on renal transplant outcomes: a scoping review","author":"Machado","year":"2024","journal-title":"J Nephrol"},{"issue":"1","key":"10.1016\/j.clinthera.2024.08.017_bib0024","doi-asserted-by":"crossref","first-page":"5504","DOI":"10.1038\/s41598-024-56242-8","article-title":"Gut diversity and the resistome as biomarkers of febrile neutropenia outcome in paediatric oncology patients undergoing hematopoietic stem cell transplantation","volume":"14","author":"Sardzikova","year":"2024","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.clinthera.2024.08.017_bib0025","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3947\/ic.2021.0015","article-title":"Evolution of antimicrobial resistance levels of ESKAPE microorganisms in a Peruvian IV-level hospital","volume":"53","author":"Flores-Paredes","year":"2021","journal-title":"Infect Chemother"},{"key":"10.1016\/j.clinthera.2024.08.017_bib0026","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.2147\/IDR.S338627","article-title":"Pathogenic characteristics and risk factors for ESKAPE pathogens infection in burn patients","volume":"12","author":"Li","year":"2021","journal-title":"Infect Drug Resist"},{"issue":"3","key":"10.1016\/j.clinthera.2024.08.017_bib0027","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jinf.2011.12.005","article-title":"Multidrug-resistant gram-negative bacterial infections after liver transplantation - spectrum and risk factors","volume":"64","author":"Zhong","year":"2012","journal-title":"J Infect"},{"key":"10.1016\/j.clinthera.2024.08.017_bib0028","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000046234","article-title":"Hospitalizations for bacterial septicemia after renal transplantation in the United States","volume":"21","author":"Abbott","year":"2001","journal-title":"Am J Nephrol"},{"issue":"3","key":"10.1016\/j.clinthera.2024.08.017_bib0029","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.anclin.2017.04.002","article-title":"Infectious complications and malignancies arising after liver transplantation","volume":"35","author":"Idossa","year":"2017","journal-title":"Anesthesiol Clin"},{"issue":"1","key":"10.1016\/j.clinthera.2024.08.017_bib0030","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s15010-018-1230-5","article-title":"Risk factors of bloodstream infections in recipients after liver transplantation: a meta-analysis","volume":"47","author":"He","year":"2019","journal-title":"Infection"},{"issue":"4","key":"10.1016\/j.clinthera.2024.08.017_bib0031","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/cld.624","article-title":"Transplanting patients with active bacterial infection","volume":"9","author":"Verna","year":"2017","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"10.1016\/j.clinthera.2024.08.017_bib0032","doi-asserted-by":"crossref","first-page":"e14631","DOI":"10.1111\/ctr.14631","article-title":"What is the optimal antimicrobial prophylaxis to prevent postoperative infectious complications after liver transplantation? - A systematic review of the literature and expert panel recommendations","author":"Campos-Varela","year":"2022","journal-title":"Clin Transplant"},{"issue":"8","key":"10.1016\/j.clinthera.2024.08.017_bib0033","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1016\/j.transproceed.2015.08.005","article-title":"Mortality Predictors in Acute Respiratory Distress Syndrome Renal Transplant Recipients With ESKAPE\/rESKAPE Pneumonia","volume":"47","author":"Chu","year":"2015","journal-title":"Transplant Proc"},{"key":"10.1016\/j.clinthera.2024.08.017_bib0034","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0196-6553(05)80197-X","article-title":"Bacteremia in transplant recipients: a prospective study of demographics, etiologic agents; risk factors, and outcomes","volume":"20","author":"Wagener","year":"1992","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.clinthera.2024.08.017_bib0035","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1111\/j.1600-6143.2007.01964.x","article-title":"Bloodstream infections among transplant recipients: results of a nationwide surveillance in Spain","volume":"7","author":"Moreno","year":"2007","journal-title":"Am J Transplant"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291824002558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291824002558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T01:03:07Z","timestamp":1732410187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291824002558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0149291824002558"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2024.08.017","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk Factors for E2SKAPE Infections and Mortality Among Liver Transplant Recipients","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2024.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}